Premier, Inc. Makes Two eHealth Deals

by | Aug 17, 2015 4:27 pm | eHealth

August is a busy month for Premier, Inc. (NASDAQ: PINC), which bills itself as a healthcare improvement company, with an alliance of 3,400 hospitals and 110,000 other providers. In the first two weeks of August 2015, the company has announced two acquisitions totaling $465 million. The first deal, for CECity, Inc. was announced on August 4 ($400 million); the second, for Healthcare Insights, LLC, was announced on August 12 ($65 million). The former company specializes in performance improvement, while the latter provides financial management systems to hospitals and healthcare systems. In August 2014, Premier acquired TheraDoc, a clinical informatics company, from Hospira (NYSE: HSP) for... Read More »

NorthStar Anesthesia Expands

by | Aug 17, 2015 4:25 pm | Physician Medical Groups, Private Equity

The market for anesthesiology groups is hot this year, with 10 deals announced through mid-August. The latest was from NorthStar Anesthesia, a portfolio company of TPG Growth, which acquired Anesthesia Staffing Consultants of Bingham Falls, Michigan. Financial terms were not disclosed. The acquisition expands NorthStar’s presence in the Midwest and increases its team of anesthesiologists and CRNAs to more than 1,600 providers working in nearly 150 facilities in 19 states. Read More »

Digital Health Care M&A

by | Aug 17, 2015 4:24 pm | eHealth

Mergers and acquisitions in the digital health category have gone through boom times and relative obscurity since the Great Recession. Companies offering revenue cycle management have always been popular targets, while data analytics and population health management companies have more to prove when it comes to ROI. With IBM (NYSE: IBM) making a splash this year with three announced acquisitions and $1 billion in spending publicly disclosed, this category is seeing more action. Through mid-August, we’ve recorded 72 transactions for eHealth companies, and $2.5 billion spent so far. Looking at the chart below, this sector is on track for another busy year. Digital Health Care Deals, 2010 to... Read More »

The Gores Group Exits with $1.325 Billion

by | Aug 17, 2015 4:11 pm | Biotechnology, Private Equity

Last week’s Biggest Deal was Mallinckrodt plc’s (NYSE: MNK) $1.325 billion acquisition of Therakos, Inc., an immunotherapy company, from The Gores Group. Gores acquired Therakos back in October 2012 for an undisclosed price from Ortho-Clinical Diagnostics. The transaction is expected to be accretive by no less than $0.10 per share to Mallinckrodt’s adjusted diluted fiscal 2016 earnings and increasingly accretive thereafter. With roughly 60% of Therakos’ revenue in the U.S., it expects fiscal 2015 net sales of $185 to $195 million, and anticipates high single-digit growth off that base going forward. Read More »